Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of DS-8201a (NSC# 807708) in Children, Adolescents, or Young Adults With Recurrent Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04616560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of DS-8201a (NSC# 807708) in Children, Adolescents, or Young Adults With Recurrent Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Recruiting
Start date
March 8, 2021
Completion date
December 31, 2027
Enrollment
55 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

desmoplastic small round cell tumor, osteosarcoma, recurrent desmoplastic small round cell tumor, recurrent kidney wilms tumor, recurrent osteosarcoma, refractory desmoplastic small round cell tumor, refractory wilms tumor, wilms tumor